Healthcare provider profile · identity verified

Andrew Wherley, M.D.

Family Practice · PONTIAC, IL · NPI 1316300593

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	394	129
Levothyroxine Sodium	Levothyroxine Sodium	287	74
Simvastatin	Simvastatin	276	75
Metoprolol Succinate	Metoprolol Succinate	242	67
Losartan Potassium	Losartan Potassium	235	58
Lisinopril	Lisinopril	219	83
Amlodipine Besylate	Amlodipine Besylate	215	64
Metformin Hcl	Metformin Hcl	200	65
Rosuvastatin Calcium	Rosuvastatin Calcium	196	50
Omeprazole	Omeprazole	194	67
Furosemide	Furosemide	181	42
Eliquis	Apixaban	163	34
Gabapentin	Gabapentin	161	53
Alprazolam	Alprazolam	159	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	148	34
Hydrochlorothiazide	Hydrochlorothiazide	147	59
Jardiance	Empagliflozin	144	40
Pantoprazole Sodium	Pantoprazole Sodium	139	38
Albuterol Sulfate Hfa	Albuterol Sulfate	135	41
Tizanidine Hcl	Tizanidine Hcl	120	49
Tramadol Hcl	Tramadol Hcl	119	38
Sertraline Hcl	Sertraline Hcl	118	34
Trazodone Hcl	Trazodone Hcl	116	31
Glipizide Er	Glipizide	113	40
Tamsulosin Hcl	Tamsulosin Hcl	109	36
Clopidogrel	Clopidogrel Bisulfate	105	29
Pravastatin Sodium	Pravastatin Sodium	90	31
Escitalopram Oxalate	Escitalopram Oxalate	89	27
Fluticasone Propionate	Fluticasone Propionate	89	38
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	28
Ozempic	Semaglutide	81	18
Potassium Chloride	Potassium Chloride	81	24
Memantine Hcl	Memantine Hcl	79	suppressed
Spironolactone	Spironolactone	79	19
Montelukast Sodium	Montelukast Sodium	73	18
Lorazepam	Lorazepam	69	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	68	29
Prednisone	Prednisone	68	57
Buspirone Hcl	Buspirone Hcl	65	17
Donepezil Hcl	Donepezil Hcl	64	11
Sucralfate	Sucralfate	63	13
Carvedilol	Carvedilol	62	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	59	20
Zolpidem Tartrate	Zolpidem Tartrate	58	14
Nifedipine Er	Nifedipine	57	19
Duloxetine Hcl	Duloxetine Hcl	55	21
Ezetimibe	Ezetimibe	55	17
Meloxicam	Meloxicam	54	26
Alendronate Sodium	Alendronate Sodium	52	13
Famotidine	Famotidine	52	18
Ropinirole Hcl	Ropinirole Hcl	51	12
Metformin Hcl Er	Metformin Hcl	50	13
Allopurinol	Allopurinol	48	20
Rybelsus	Semaglutide	47	12
Venlafaxine Hcl Er	Venlafaxine Hcl	46	17
Azithromycin	Azithromycin	45	42
Warfarin Sodium	Warfarin Sodium	45	suppressed
Naproxen	Naproxen	43	14
Atenolol	Atenolol	42	16
Enalapril Maleate	Enalapril Maleate	42	12
Paroxetine Hcl	Paroxetine Hcl	42	13
Metoprolol Tartrate	Metoprolol Tartrate	41	19
Meclizine Hcl	Meclizine Hcl	40	17
Baclofen	Baclofen	38	12
Pregabalin	Pregabalin	38	14
Propranolol Hcl	Propranolol Hcl	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	15
Hydralazine Hcl	Hydralazine Hcl	37	suppressed
Fenofibrate	Fenofibrate	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	12
Dicyclomine Hcl	Dicyclomine Hcl	35	suppressed
Ventolin Hfa	Albuterol Sulfate	34	14
Oxybutynin Chloride Er	Oxybutynin Chloride	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Klor-Con M20	Potassium Chloride	32	17
Triamcinolone Acetonide	Triamcinolone Acetonide	30	16
Hydroxyzine Hcl	Hydroxyzine Hcl	29	20
Aripiprazole	Aripiprazole	28	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	28	suppressed
Glipizide	Glipizide	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	26
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	22
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Symbicort	Budesonide/Formoterol Fumarate	23	suppressed
Topiramate	Topiramate	23	suppressed
Celecoxib	Celecoxib	22	suppressed
Januvia	Sitagliptin Phosphate	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Nystatin	Nystatin	20	14
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	11
Fenofibrate	Fenofibrate Nanocrystallized	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Mirtazapine	Mirtazapine	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	11
Finasteride	Finasteride	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Mounjaro	Tirzepatide	15	suppressed
Novolog	Insulin Aspart	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Temazepam	Temazepam	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Xarelto	Rivaroxaban	13	suppressed
Byetta	Exenatide	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Risperidone	Risperidone	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	11	suppressed
Estradiol	Estradiol	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error